What is the recommended management of pneumococcal meningitis?

Management of Pneumococcal Meningitis

Start empiric therapy with ceftriaxone 2 g IV every 12 hours or cefotaxime 2 g IV every 6 hours immediately upon suspicion of bacterial meningitis, and add dexamethasone 10 mg IV every 6 hours for 4 days beginning with or before the first antibiotic dose. 1, 2

Empiric Antibiotic Therapy

Standard Initial Regimen

• Adults <60 years: Initiate ceftriaxone 2 g IV every 12 hours OR cefotaxime 2 g IV every 6 hours as first-line therapy. 1, 2
• Adults ≥60 years: Use the same cephalosporin regimen PLUS amoxicillin 2 g IV every 4 hours to cover Listeria monocytogenes. 1, 2

When to Add Vancomycin

• Add vancomycin 15–20 mg/kg IV every 12 hours (targeting trough levels 15–20 µg/mL) if penicillin-resistant pneumococci are suspected, particularly if the patient has recently traveled from regions with high resistance rates (e.g., Spain, Eastern Europe, parts of Asia). 1, 2
• Alternatively, rifampicin 600 mg IV/PO every 12 hours can be added instead of vancomycin in areas with known resistance. 1, 2
• Important caveat: Do not routinely add vancomycin empirically in all cases—reserve it for confirmed or strongly suspected cephalosporin resistance to avoid unnecessary nephrotoxicity and ototoxicity. 2, 3

β-Lactam Allergy

• If documented β-lactam allergy exists, substitute with chloramphenicol 25 mg/kg IV every 6 hours. 1, 2

Definitive Antibiotic Therapy (After Susceptibility Results)

Penicillin-Sensitive Strains (MIC ≤0.06 mg/L)

• Continue ceftriaxone 2 g IV every 12 hours OR cefotaxime 2 g IV every 6 hours. 1, 2
• Benzylpenicillin 2.4 g IV every 4 hours is an acceptable alternative. 1, 2

Penicillin-Resistant but Cephalosporin-Sensitive (Penicillin MIC >0.06 mg/L, Cephalosporin MIC ≤0.5 mg/L)

• Maintain ceftriaxone 2 g IV every 12 hours OR cefotaxime 2 g IV every 6 hours alone—no additional agents required. 1, 2
• High-dose cephalosporin therapy (300 mg/kg/day of cefotaxime) has been shown to effectively treat strains with MICs up to 2 mg/L for either penicillin or cefotaxime, even in resistant cases. 3

Dual-Resistant Strains (Penicillin AND Cephalosporin MIC >0.5 mg/L)

• Continue ceftriaxone 2 g IV every 12 hours OR cefotaxime 2 g IV every 6 hours PLUS vancomycin 15–20 mg/kg IV every 12 hours (adjust to trough levels) AND rifampicin 600 mg IV/PO every 12 hours. 1, 2
• This triple-drug regimen is essential for dual-resistant isolates to ensure adequate CSF penetration and bacterial eradication. 1, 2

Duration of Antibiotic Treatment

• 10 days total if the patient has clinically recovered by day 10 (stable vital signs, improving mental status, no new neurological deficits). 1, 2
• Extend to 14 days total if recovery is not achieved by day 10 or if the patient shows persistent fever, altered mental status, or worsening neurological signs. 1, 2
• Always treat for 14 days if the infection is caused by penicillin-resistant or cephalosporin-resistant strains, regardless of clinical response. 1, 2
• Common pitfall: Do not stop antibiotics at day 10 if the patient has not fully recovered—this increases the risk of relapse and treatment failure. 2

Adjunctive Dexamethasone

• Administer dexamethasone 10 mg IV every 6 hours for 4 days, starting with or immediately before the first antibiotic dose. 2, 4
• Early dexamethasone (given before or with the first antibiotic) reduces mortality and neurological sequelae specifically in pneumococcal meningitis. 2, 4
• Discontinue dexamethasone by day 4; prolonged courses beyond this window provide no additional benefit and may increase complications. 2

Monitoring and Repeat Imaging

Indications for Repeat CT or MRI (MRI Preferred)

• Obtain repeat imaging when any of the following occur: 2
  • Glasgow Coma Scale decline ≥2 points
  • New focal neurological deficit (e.g., hemiparesis, cranial nerve palsy)
  • New or worsening seizure activity
  • Persistent fever beyond 7–10 days of appropriate therapy
  • Clinical deterioration suggesting complications such as brain abscess, hydrocephalus, or ventriculitis

Repeat Lumbar Puncture

• Routine repeat lumbar puncture is not indicated in clinically stable patients. 2
• Perform repeat LP only if deterioration suggests treatment failure, secondary intracranial infection, or if dual-resistant strains are identified and clinical response is uncertain. 2, 5

ICU Admission Criteria

• Admit to ICU if Glasgow Coma Scale ≤12 OR a drop of ≥2 points from baseline. 2
• Also admit if the patient experiences seizures requiring ongoing management or develops hemodynamic instability. 2
• Patients with stable neurological status (GCS 15) may be managed on a regular ward with neurological checks every 4–6 hours. 2

Prophylaxis and Prevention

Close Contact Prophylaxis

• No antibiotic prophylaxis is recommended for contacts of patients with pneumococcal meningitis (unlike meningococcal meningitis, which requires prophylaxis). 6, 2

Vaccination After Recovery

• Vaccinate patients with pneumococcal conjugate vaccine (PCV20 or PCV15) and pneumococcal polysaccharide vaccine (PPSV23) after recovery from pneumococcal meningitis to prevent recurrence. 6
• The recurrence risk of pneumococcal meningitis is 1–5%, making post-infection vaccination highly beneficial. 6
• Also vaccinate patients with CSF leakage along with surgical reconstruction of the dural barrier. 6

Common Pitfalls to Avoid

• Do not delay antibiotics beyond 1 hour of arrival for suspected meningitis—initiation within 1 hour significantly improves outcomes. 7, 2
• Do not add vancomycin empirically in all cases—reserve it for confirmed or strongly suspected cephalosporin resistance to avoid unnecessary toxicity. 2, 3
• Do not stop antibiotics at day 10 if the patient has not fully recovered—extend therapy to 14 days to prevent relapse. 2
• Do not perform routine repeat lumbar punctures solely to monitor CSF parameters in stable patients—this does not improve outcomes and adds discomfort. 2
• Do not use therapeutic hypothermia or routine adjuncts such as mannitol, acetaminophen, prophylactic antiepileptic drugs, or hypertonic saline without specific indications—these have not been shown to improve outcomes and may cause harm. 6, 2
• Do not miss scheduled ceftriaxone doses in CNS infections—even a single missed dose can lead to sub-therapeutic CSF concentrations and jeopardize bacterial eradication. 8